The global market
for bioengineered protein drugs was $172.5 in 2016 and it is expected to reach $228.4 billion
by 2021.

                 
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 774078.


Pharma Factory copyright 2018